Comparison results
| Results: Differences General | ✘Acute salpingitis | ✘Biochemical pregnancy | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
| adnexitis | 74% | — | ||||||||||
| consequences of childbirth | — | 87% | ||||||||||
| salpingitis | 73% | — | ||||||||||
| hormonal failure | — | 65% | ||||||||||
| inflammation of the ovaries | 73% | — | ||||||||||
| progesterone deficiency | — | 62% | ||||||||||
| vulvovaginitis | 62% | — | ||||||||||
| delay menstruation | — | 60% | ||||||||||
| vulva infections | 62% | — | ||||||||||
| happy | — | 58% | ||||||||||
| intra-phase infections | 61% | — | ||||||||||
| premature menstruation | — | 56% | ||||||||||
| appendages of the uterus | 58% | — | ||||||||||
| habitual miscarriage | — | 52% | ||||||||||
| sactosalpinx | 51% | — | ||||||||||
| nose thrombophilia | — | 49% | ||||||||||
| ovarian cyst during pregnancy | 48% | — | ||||||||||
| pregnancy | 31% | 78% | ||||||||||
| inflammation | 44% | — | ||||||||||
| miscarriage | — | 46% | ||||||||||
| ectopic pregnancy | 35% | — | ||||||||||
| 2 pregnancy | — | 46% | ||||||||||
| does not recognize | 35% | — | ||||||||||
| menstruation disorder | — | 46% | ||||||||||
| endometritis | 31% | — | ||||||||||
| speech absence | — | 45% | ||||||||||
| lower back pain | 28% | — | ||||||||||
| early development | — | 39% | ||||||||||
| history of surgery | 27% | — | ||||||||||
| aggressive | — | 39% | ||||||||||
| abortions | 27% | — | ||||||||||
| there are no complaints | — | 34% | ||||||||||
| back pain | 26% | — | ||||||||||
| drug disease | — | 33% | ||||||||||
| fighting | 24% | — | ||||||||||
| blood diseases | — | 33% | ||||||||||
| abdominal pain | 23% | — | ||||||||||
| consequences of taking medications | — | 32% | ||||||||||
| feeling of heat | 22% | — | ||||||||||
| impaired uterine function | 37% | 42% | ||||||||||
| high temperature | 22% | — | ||||||||||
| female pelvic organs | 53% | 53% | ||||||||||
| onset of illness | 21% | — | ||||||||||
Instructions
Video
|